FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892456672> ?p ?o ?g. }

• W2892456672 abstract "The risk of recurrence for endocrine-treated breast cancer patients persists for many years or even decades following surgery and apparently successful adjuvant therapy. This period of dormancy and acquired resistance is inherently difficult to investigate; previous efforts have been limited to in-vitro or in-vivo approaches. In this study, sequential tumour samples from patients receiving extended neoadjuvant aromatase inhibitor therapy were characterised as a novel clinical model. Consecutive tumour samples from 62 patients undergoing extended (4–45 months) neoadjuvant aromatase inhibitor therapy with letrozole were subjected to transcriptomic and proteomic analysis, representing before (≤ 0), early (13–120 days), and long-term (> 120 days) neoadjuvant aromatase inhibitor therapy with letrozole. Patients with at least a 40% initial reduction in tumour size by 4 months of treatment were included. Of these, 42 patients with no subsequent progression were classified as “dormant”, and the remaining 20 patients as “acquired resistant”. Changes in gene expression in dormant tumours begin early and become more pronounced at later time points. Therapy-induced changes in resistant tumours were common features of treatment, rather than being specific to the resistant phenotype. Comparative analysis of long-term treated dormant and resistant tumours highlighted changes in epigenetics pathways including DNA methylation and histone acetylation. The DNA methylation marks 5-methylcytosine and 5-hydroxymethylcytosine were significantly reduced in resistant tumours compared with dormant tissues after extended letrozole treatment. This is the first patient-matched gene expression study investigating long-term aromatase inhibitor-induced dormancy and acquired resistance in breast cancer. Dormant tumours continue to change during treatment whereas acquired resistant tumours more closely resemble their diagnostic samples. Global loss of DNA methylation was observed in resistant tumours under extended treatment. Epigenetic alterations may lead to escape from dormancy and drive acquired resistance in a subset of patients, supporting a potential role for therapy targeted at these epigenetic alterations in the management of resistance to oestrogen deprivation therapy." @default.
• W2892456672 created "2018-10-05" @default.
• W2892456672 creator A5014803952 @default.
• W2892456672 creator A5031138706 @default.
• W2892456672 creator A5041581672 @default.
• W2892456672 creator A5044117233 @default.
• W2892456672 creator A5047364768 @default.
• W2892456672 creator A5048450614 @default.
• W2892456672 creator A5049960303 @default.
• W2892456672 creator A5055139694 @default.
• W2892456672 creator A5059605240 @default.
• W2892456672 creator A5068209246 @default.
• W2892456672 date "2019-01-07" @default.
• W2892456672 modified "2023-10-18" @default.
• W2892456672 title "Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours" @default.
• W2892456672 cites W1492600479 @default.
• W2892456672 cites W1493097681 @default.
• W2892456672 cites W1731609214 @default.
• W2892456672 cites W1917948530 @default.
• W2892456672 cites W1946158680 @default.
• W2892456672 cites W1967949926 @default.
• W2892456672 cites W1968328642 @default.
• W2892456672 cites W1990876362 @default.
• W2892456672 cites W1992533338 @default.
• W2892456672 cites W2003236418 @default.
• W2892456672 cites W2006986876 @default.
• W2892456672 cites W2028672331 @default.
• W2892456672 cites W2034775984 @default.
• W2892456672 cites W2035000722 @default.
• W2892456672 cites W2036694038 @default.
• W2892456672 cites W2041799604 @default.
• W2892456672 cites W2044702943 @default.
• W2892456672 cites W2044738282 @default.
• W2892456672 cites W2070050178 @default.
• W2892456672 cites W2070840700 @default.
• W2892456672 cites W2076679216 @default.
• W2892456672 cites W2080752012 @default.
• W2892456672 cites W2082217934 @default.
• W2892456672 cites W2091789935 @default.
• W2892456672 cites W2097255042 @default.
• W2892456672 cites W2099920641 @default.
• W2892456672 cites W2100971064 @default.
• W2892456672 cites W2106608030 @default.
• W2892456672 cites W2107617686 @default.
• W2892456672 cites W2114694330 @default.
• W2892456672 cites W2121719523 @default.
• W2892456672 cites W2123657823 @default.
• W2892456672 cites W2123879591 @default.
• W2892456672 cites W2124602578 @default.
• W2892456672 cites W2124964054 @default.
• W2892456672 cites W2128952169 @default.
• W2892456672 cites W2131174392 @default.
• W2892456672 cites W2135581618 @default.
• W2892456672 cites W2139583647 @default.
• W2892456672 cites W2145476705 @default.
• W2892456672 cites W2146320180 @default.
• W2892456672 cites W2148064779 @default.
• W2892456672 cites W2149575442 @default.
• W2892456672 cites W2159303972 @default.
• W2892456672 cites W2161109798 @default.
• W2892456672 cites W2163860217 @default.
• W2892456672 cites W2172215633 @default.
• W2892456672 cites W2172557341 @default.
• W2892456672 cites W2214665719 @default.
• W2892456672 cites W2259802687 @default.
• W2892456672 cites W2262974530 @default.
• W2892456672 cites W2276640786 @default.
• W2892456672 cites W2338403880 @default.
• W2892456672 cites W2346426904 @default.
• W2892456672 cites W2411345140 @default.
• W2892456672 cites W2413654632 @default.
• W2892456672 cites W2473709326 @default.
• W2892456672 cites W2558077257 @default.
• W2892456672 cites W2558458383 @default.
• W2892456672 cites W2564885659 @default.
• W2892456672 cites W2574190322 @default.
• W2892456672 cites W2588107168 @default.
• W2892456672 cites W2599099937 @default.
• W2892456672 cites W2613457531 @default.
• W2892456672 cites W2767600184 @default.
• W2892456672 cites W4234586755 @default.
• W2892456672 cites W4235084198 @default.
• W2892456672 doi "https://doi.org/10.1186/s13058-018-1089-5" @default.
• W2892456672 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6323855" @default.
• W2892456672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30616553" @default.
• W2892456672 hasPublicationYear "2019" @default.
• W2892456672 type Work @default.
• W2892456672 sameAs 2892456672 @default.
• W2892456672 citedByCount "28" @default.
• W2892456672 countsByYear W28924566722019 @default.
• W2892456672 countsByYear W28924566722020 @default.
• W2892456672 countsByYear W28924566722021 @default.
• W2892456672 countsByYear W28924566722022 @default.
• W2892456672 countsByYear W28924566722023 @default.
• W2892456672 crossrefType "journal-article" @default.
• W2892456672 hasAuthorship W2892456672A5014803952 @default.
• W2892456672 hasAuthorship W2892456672A5031138706 @default.
• W2892456672 hasAuthorship W2892456672A5041581672 @default.
• W2892456672 hasAuthorship W2892456672A5044117233 @default.
• W2892456672 hasAuthorship W2892456672A5047364768 @default.

• next